MW: 27,334 Da. Purity >90 % as determined by SDS-PAGE. Background: Mitogen-activated protein kinase 9 (MAPK9), also well known as c-Jun N-terminal kinase (JNK2), is a member of MAP kinase subfamily belonging to the protein kinase superfamily. MAPK9 responds to activation by environmental stress and pro-inflammatory cytokines by phosphorylating a number of transcription factors, such as c-Jun and ATF2. The crystal structure of human JNK2 complexed with an indazole inhibitor by applying a high-thr
Size
0.02 mg, 0.05 mg
Concentration
n/a
Applications
The recombinant human MAPK9 consists of 435 amino acids and predicts a molecular mass of 49.5 kDa as estimated in SDS-PAGE under reducing conditions.